OBJECTIVE: To assess the test qualities of four screening methods to detect cervical intra-epithelial neoplasia in an urban African setting. METHOD: Six hundred fifty-three women, attending a family planning clinic in Nairobi (Kenya), underwent four concurrent screening methods: pap smear, visual inspection with acetic acid (VIA), PCR for high risk human papillomavirus (HR HPV) and cervicography. The presence of cervical intra-epithelial neoplasia (CIN) was verified by colposcopy or biopsy. RESULT: Sensitivity (for CIN2 or higher) and specificity (to exclude any CIN or cancer) were 83.3% (95% CI [73.6, 93.0]) and 94.6% (95% CI [92.6, 96.5]), respectively, for pap smear; 73.3% (95% CI [61.8, 84.9]) and 80.0% (95% CI [76.6, 83.4]) for VIA; 94.4% (95% CI [84.6, 98.8]) and 73.9% (95% CI [69.7, 78.2]) for HR HPV; and 72.3% (95% CI [59.1, 85.6]) and 93.2% (95% CI [90.8, 95.7]) for cervicography. CONCLUSION: The pap smear had the highest specificity (94.6%) and HPV testing the highest sensitivity (94.4%). The visual methods, VIA and cervicography, were similar and showed an accuracy in between the former two tests.
OBJECTIVE: To assess the test qualities of four screening methods to detect cervical intra-epithelial neoplasia in an urban African setting. METHOD: Six hundred fifty-three women, attending a family planning clinic in Nairobi (Kenya), underwent four concurrent screening methods: pap smear, visual inspection with acetic acid (VIA), PCR for high risk human papillomavirus (HR HPV) and cervicography. The presence of cervical intra-epithelial neoplasia (CIN) was verified by colposcopy or biopsy. RESULT: Sensitivity (for CIN2 or higher) and specificity (to exclude any CIN or cancer) were 83.3% (95% CI [73.6, 93.0]) and 94.6% (95% CI [92.6, 96.5]), respectively, for pap smear; 73.3% (95% CI [61.8, 84.9]) and 80.0% (95% CI [76.6, 83.4]) for VIA; 94.4% (95% CI [84.6, 98.8]) and 73.9% (95% CI [69.7, 78.2]) for HR HPV; and 72.3% (95% CI [59.1, 85.6]) and 93.2% (95% CI [90.8, 95.7]) for cervicography. CONCLUSION: The pap smear had the highest specificity (94.6%) and HPV testing the highest sensitivity (94.4%). The visual methods, VIA and cervicography, were similar and showed an accuracy in between the former two tests.
Authors: Karen Haney; Pushpa Tandon; Rao Divi; Miguel R Ossandon; Houston Baker; Paul C Pearlman Journal: IEEE J Transl Eng Health Med Date: 2017-11-23 Impact factor: 3.316
Authors: Jenell S Coleman; Michelle S Cespedes; Susan Cu-Uvin; Rose J Kosgei; May Maloba; Jean Anderson; Timothy Wilkin; Antoine Jaquet; Julia Bohlius; Kathryn Anastos; Kara Wools-Kaloustian Journal: J Low Genit Tract Dis Date: 2016-01 Impact factor: 1.925
Authors: Patti E Gravitt; Proma Paul; Hormuzd A Katki; Haripriya Vendantham; Gayatri Ramakrishna; Mrudula Sudula; Basany Kalpana; Brigitte M Ronnett; K Vijayaraghavan; Keerti V Shah Journal: PLoS One Date: 2010-10-28 Impact factor: 3.240
Authors: Megan J Huchko; Jennifer Sneden; George Sawaya; Karen Smith-McCune; May Maloba; Naila Abdulrahim; Elizabeth A Bukusi; Craig R Cohen Journal: Int J Cancer Date: 2014-06-10 Impact factor: 7.396
Authors: Adhemar Longatto-Filho; Paulo Naud; Sophie Fm Derchain; Cecília Roteli-Martins; Sílvio Tatti; Luciano Serpa Hammes; Luis Otavio Sarian; Mojca Eržen; Margherita Branca; Jean Carlos de Matos; Renata Gontijo; Marina Y S Maeda; Temístocles Lima; Silvano Costa; Stina Syrjänen; Kari Syrjänen Journal: Virchows Arch Date: 2012-05-05 Impact factor: 4.064
Authors: Michael H Chung; Kevin P McKenzie; Hugo De Vuyst; Barbra A Richardson; Farzana Rana; Ritesh Pamnani; Julia W Njoroge; Evans Nyongesa-Malava; Samah R Sakr; Grace C John-Stewart; Nelly R Mugo Journal: AIDS Date: 2013-11-28 Impact factor: 4.177
Authors: N Li; J-F Shi; S Franceschi; W-H Zhang; M Dai; B Liu; Y-Z Zhang; L-K Li; R-F Wu; H De Vuyst; M Plummer; Y-L Qiao; G Clifford Journal: Br J Cancer Date: 2009-01-06 Impact factor: 7.640
Authors: H Rafferty; A S Sturt; C R Phiri; E L Webb; M Mudenda; J Mapani; P L A M Corstjens; G J van Dam; A Schaap; H Ayles; R J Hayes; L van Lieshout; I Hansingo; A L Bustinduy Journal: BMC Infect Dis Date: 2021-07-17 Impact factor: 3.090